Drug Information Analysis Service

Abstract

Get full access to this article

View all access options for this article.

References

Ignoffo

Friedman

. Therapy of local toxicities caused by extravasation of cancer chemotherapeutic drugs. Cancer Treat Rev 1980; 7: 7–27.

Dorr

. Chemotherapy extravasation. Highlights Antineoplast Drugs 1984; May/June: 1–5.

Svingen

Powis

Appel

Scott

. Protection against Adriamycin-induced skin necrosis in the rat by dimethyl sulfoxide and alpha-tocopherol. Cancer Res 1981; 41: 3395–9.

Bartokowski-Dodds

Daniels

. Use of sodium bicarbonate as a means of ameliorating doxorubicin-induced dermal necrosis in rats. Cancer Chemother Pharmacol 1980; 4: 179–81.

Gaze

. Tissue necrosis caused by commonly used intravenous infusions. Lancet 1978; 2: 417–9.

Bhalla

Hindenburg

Taub

Isolation and characterization of an anthracycline-resistant human leukemic cell line. Cancer Res 1985; 45: 3657–66.

Groos

Walker

Master

JRW

. Intravesical chemotherapy: studies on the relationship between pH and cytotoxicity. Cancer 1986; 58: 1199–203.

Dorr

Alberts

Chem

HSG

. The limited role of corticosteroids in ameliorating experimental doxorubicin skin toxicity in the mouse. Cancer Chemother Pharmacol 1980; 5: 17–20.

Barlock

Howser

Hubbard

. Nursing management of Adriamycin extravasation. Am J Nurs 1979; 79: 94–6.

10.

Rudolph

Stein

Pattillo

. Skin ulcers due to Adriamycin. Cancer 1976; 38: 1087–94.

11.

Luedke

Kennedy

Rietschel

. Histopathogenesis of skin and subcutaneous injury induced by Adriamycin. Plast Reconstr Surg 1979; 63: 463–5.

12.

Cohen

. Amelioration of Adriamycin skin necrosis: an experimental study. Cancer Treat Rep 1979; 63: 1003–4.

13.

Dorr

Alberts

Stone

. Cold protection and heat enhancement of doxorubicin skin toxicity in the mouse. Cancer Treat Rep 1985; 69: 431–7.

14.

Larson

. What is the appropriate management of tissue extravasation by antitumor agents? Plast Reconstr Surg 1985; 73: 397–402.

15.

Larson

. Treatment of tissue extravasation by antitumor agents. Cancer 1982; 49: 1796–9.

16.

Rudolf

Larson

. Etiology and treatment of chemotherapeutic agent extravasation: a review. J Clin Oncol 1987; 5: 1116–26.

17.

Mimnaugh

Kennedy

Trush

Sinha

. Adriamycin-enhanced membrane lipid peroxidation in isolated rat nuclei. Cancer Res 1985; 45: 3296–304.

18.

Bachur

Gordon

Gee

. A general mechanism for microsomal activation of quinone anticancer agents to free radicals. Cancer Res 1978; 38: 1745–50.

19.

Desai

Teres

. Prevention of doxorubicin-induced skin ulcers in the rat and pig with dimethyl sulfoxide (DMSO). Cancer Treat Rep 1982; 66: 1371–4.

20.

Dorr

Alberts

. Failure of DMSO and vitamin E to prevent doxorubicin skin ulceration in the mouse. Cancer Treat Rep 1983; 67: 499–501.

21.

Ludwig

Stoll

Obrist

Obrecht

. Prevention of cytotoxic drug induced skin ulcers with dimethyl sulfoxide (DMSO) and alpha-tocopherol. Eur J Cancer Clin Oncol 1987; 23: 327–9.

22.

Dorr

Alberts

. Pharmacologic antidotes to experimental doxorubicin skin toxicity: a suggested role for beta-adrenergic compounds. Cancer Treat Rep 1981; 65: 1001–6.

23.

Powell

Duell

Voorhees

. Beta-adrenergic stimulation of endogenous epidermal cyclic AMP formation. Arch Dermatol 1971; 104: 359–65.

24.

Reilly

Neifield

Roseberg

. Clinical course and management of accidental Adriamycin extravasation. Cancer 1977; 40: 2053–6.

25.

Pitkanen

Asko-Seljavaana

Grohn

Adriamycin extravasation: surgical treatment and possible prevention of skin and soft-tissue injuries. J Surg Oncol 1983; 23: 259–62.

26.

Rojkind

Mourelle

Kershenobich

. Anti-inflammatory and antifibrogenic activities of colchicine: treatment of liver cirrhosis. Prog Clin Biol Res 1984; 154: 475–89.

27.

Bienkowski

Cowan

McDonald

Crystal

. Degradation of newly synthesized collagen. J Biol Chem 1978; 253: 4356–63.

28.

Rojkind

Uribe

Kershenobich

. Colchicine and the treatment of liver cirrhosis. Lancet 1973; 1: 38–9.

29.

Tapalaga

Dumitrascu

Cotul

. Colchicine treatment effects on liver cirrhosis assessed by liver flow measurements. Med Interne 1986; 24: 69–73.

30.

Frysak

Dusek

Jezdinska

. The effects of long-term therapy with colchicine on clinical and morphological features of liver cirrhosis. Acta Univ Palacki Olomuc Fac Med 1987; 116: 253–61.

31.

Kershenobich

Vargas

Garcia-Tsao

Pereztamayo

Gent

Rojkind

. Colchicine in the treatment of cirrhosis of the liver. N Engl J Med 1988; 318: 1709–13.

32.

Boyer

Ransohoff

. Is colchicine effective therapy for cirrhosis? N Engl J Med 1988; 318: 1751–2.

33.

McEvoy

, ed. American Hospital Formulary Service drug information 88. Bethesda, MD: American Society of Hospital Pharmacists, 1988: 2139–41.